NO EFFECT OF INTRAMUSCULAR GOLD THERAPY ON SEROLOGICAL PARAMETERS OF HELICOBACTER-PYLORI INFECTION IN PATIENTS WITH RHEUMATOID-ARTHRITIS - A 12-MONTH PROSPECTIVE-STUDY
S. Tenwolde et al., NO EFFECT OF INTRAMUSCULAR GOLD THERAPY ON SEROLOGICAL PARAMETERS OF HELICOBACTER-PYLORI INFECTION IN PATIENTS WITH RHEUMATOID-ARTHRITIS - A 12-MONTH PROSPECTIVE-STUDY, Annals of the Rheumatic Diseases, 53(6), 1994, pp. 400-402
Objectives-To assess prospectively the influence of intramuscular gold
therapy on Helicobacter pylori serology in patients with rheumatoid a
rthritis (RA). Methods-Fifty patients with RA were started on intramus
cular gold or chloroquine, as the control group and were followed sero
logically for H pylori infection for 12 months. Results-Twelve patient
s treated with gold and eight control patients treated with chloroquin
e, all with serological evidence for H pylori infection, showed no sig
nificant decline of IgA and IgG anti-H pylori antibody levels or serum
pepsinogen A and C revels. Total serum IgA and IgG levels declined si
gnificantly during gold therapy, while they remained unchanged during
chloroquine therapy. Conclusions-Instramuscular gold therapy in patien
ts with RA does not influence the serological parameters of H pylori i
nfection.